mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.1 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |